Latest News & Features
Americas
The US Supreme Court is set to consider today whether to take on a long running patent dispute between Sequenom and Ariosa Diagnostics centring on pre-natal testing. 23 June 2016
Big Pharma
After the “EU Summary of Clinical Trial Results for Laypersons” was published for consultation in June, a counsel from Novo Nordisk discussed the importance of providing reliable information for patients at an industry event in London. 23 June 2016
Big Pharma
While pharmaceutical companies are more likely to seek patent protection for their inventions, trade secrets can be useful too, particularly following two recent legislative developments, say Andy Sanderson and Ling Zhuang of Potter Clarkson. 23 June 2016
Americas
A US advisory panel has reportedly approved the use of the CRISPR/Cas9 gene-editing technology on humans for the first time, as part of a study designed to target three types of cancer. 22 June 2016
Asia-Pacific
Japan-based Fujifilm has signed a patent licensing agreement with a Chinese company centring on an ingredient used in its anti-influenza drug Avigan. 22 June 2016
Americas
The US Supreme Court has invited the solicitor general to file briefs in the Amgen v Sandoz biosimilars case in order to obtain the Obama administration’s view on the dispute between the two companies. 22 June 2016
Big Pharma
A Spain-based pharmaceutical company has applied to trademark ‘Brexit’, the term coined for the UK’s potential departure from the EU. 22 June 2016
Americas
The Canadian Intellectual Property Office has updated its guidelines on procedural and examination practices, with some changes affecting biotechnology and medicinal inventions, explain Jason Markwell and Stephanie Anderson of Belmore Neidrauer. 22 June 2016
Americas
The US National Institutes of Health has decided not to exercise its “march in-rights” for the Xtandi prostate drug, which is marketed by Astellas Pharma, despite calls from politicians to license the drug in a bid to lower its price. 21 June 2016
Americas
Japan-based pharmaceutical company Daiichi Sankyo has secured victory in an inter partes review against Canada-based Alethia Biotherapeutics. 20 June 2016